- Reads 1
- Votes 0
- Parts 1
- Time <5 mins
Ongoing, First published Feb 21, 2019
Blosozumab binds SOST, a negative regulator of osteoblast activity. Blocking SOST activity can lead to increased bone density. https://www.creativebiolabs.net/Anti-Human-SOST-Therapeutic-Antibody-Blosozumab-13650.htmAll Rights Reserved
Table of contents
Sign up to add Blosozumab to your library and receive updates
or
You may also like
You may also like
